🚀 VC round data is live in beta, check it out!
Sensus Healthcare Valuation Multiples
Discover revenue and EBITDA valuation multiples for Sensus Healthcare and similar public comparables like Fractyl Health, Senzime, Nexstim, Pangaea Oncology and more.
Sensus Healthcare Overview
About Sensus Healthcare
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.
Founded
2010
HQ
Employees
54
Website
Financials (LTM)
EV
$52M
Sensus Healthcare Financials
Sensus Healthcare reported last 12-month revenue of $27M and negative EBITDA of ($9M).
In the same LTM period, Sensus Healthcare generated $12M in gross profit, ($9M) in EBITDA losses, and had net loss of ($7M).
Revenue (LTM)
Sensus Healthcare P&L
In the most recent fiscal year, Sensus Healthcare reported revenue of $27M and EBITDA of ($10M).
Sensus Healthcare expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $27M | XXX | $27M | XXX | XXX | XXX |
| Gross Profit | $12M | XXX | $12M | XXX | XXX | XXX |
| Gross Margin | 44% | XXX | 43% | XXX | XXX | XXX |
| EBITDA | ($9M) | XXX | ($10M) | XXX | XXX | XXX |
| EBITDA Margin | (32%) | XXX | (35%) | XXX | XXX | XXX |
| EBIT Margin | (33%) | XXX | (37%) | XXX | XXX | XXX |
| Net Profit | ($7M) | XXX | ($8M) | XXX | XXX | XXX |
| Net Margin | (25%) | XXX | (28%) | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Sensus Healthcare Stock Performance
Sensus Healthcare has current market cap of $74M, and enterprise value of $52M.
Market Cap Evolution
Sensus Healthcare's stock price is $4.47.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $52M | $74M | 0.1% | XXX | XXX | XXX | $-0.47 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialSensus Healthcare Valuation Multiples
Sensus Healthcare trades at 1.9x EV/Revenue multiple, and (6.0x) EV/EBITDA.
EV / Revenue (LTM)
Sensus Healthcare Financial Valuation Multiples
As of April 11, 2026, Sensus Healthcare has market cap of $74M and EV of $52M.
Equity research analysts estimate Sensus Healthcare's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Sensus Healthcare has a P/E ratio of (10.9x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $74M | XXX | $74M | XXX | XXX | XXX |
| EV (current) | $52M | XXX | $52M | XXX | XXX | XXX |
| EV/Revenue | 1.9x | XXX | 1.9x | XXX | XXX | XXX |
| EV/EBITDA | (6.0x) | XXX | (5.4x) | XXX | XXX | XXX |
| EV/EBIT | (5.7x) | XXX | (5.0x) | XXX | XXX | XXX |
| EV/Gross Profit | 4.3x | XXX | 4.4x | XXX | XXX | XXX |
| P/E | (10.9x) | XXX | (9.5x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | 156.5x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Sensus Healthcare Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Sensus Healthcare Margins & Growth Rates
Sensus Healthcare's revenue in the last 12 month grew by 9%.
Sensus Healthcare's revenue per employee in the last FY averaged $0.5M, while opex per employee averaged $0.4M for the same period.
Sensus Healthcare's rule of 40 is (22%) (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Sensus Healthcare's rule of X is (22%) (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Sensus Healthcare Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 9% | XXX | 0% | XXX | XXX | XXX |
| EBITDA Margin | (32%) | XXX | (35%) | XXX | XXX | XXX |
| EBITDA Growth | (48%) | XXX | (37%) | XXX | XXX | XXX |
| Rule of 40 | — | XXX | (22%) | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | (22%) | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.5M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.4M | XXX | XXX | XXX |
| S&M Expenses to Revenue | 24% | XXX | 24% | XXX | XXX | XXX |
| G&A Expenses to Revenue | 27% | XXX | 29% | XXX | XXX | XXX |
| R&D Expenses to Revenue | 26% | XXX | 28% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 81% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Sensus Healthcare Public Comps
See public comps and valuation multiples for other Medical Devices comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Fractyl Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Senzime | XXX | XXX | XXX | XXX | XXX | XXX |
| Nexstim | XXX | XXX | XXX | XXX | XXX | XXX |
| Pangaea Oncology | XXX | XXX | XXX | XXX | XXX | XXX |
| Meditera | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Sensus Healthcare M&A Activity
Sensus Healthcare acquired XXX companies to date.
Last acquisition by Sensus Healthcare was on XXXXXXXX, XXXXX. Sensus Healthcare acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Sensus Healthcare
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialSensus Healthcare Investment Activity
Sensus Healthcare invested in XXX companies to date.
Sensus Healthcare made its latest investment on XXXXXXXX, XXXXX. Sensus Healthcare invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Sensus Healthcare
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Sensus Healthcare
| When was Sensus Healthcare founded? | Sensus Healthcare was founded in 2010. |
| Where is Sensus Healthcare headquartered? | Sensus Healthcare is headquartered in United States. |
| How many employees does Sensus Healthcare have? | As of today, Sensus Healthcare has over 54 employees. |
| Who is the CEO of Sensus Healthcare? | Sensus Healthcare's CEO is Joseph Sardano. |
| Is Sensus Healthcare publicly listed? | Yes, Sensus Healthcare is a public company listed on Nasdaq. |
| What is the stock symbol of Sensus Healthcare? | Sensus Healthcare trades under SRTS ticker. |
| When did Sensus Healthcare go public? | Sensus Healthcare went public in 2016. |
| Who are competitors of Sensus Healthcare? | Sensus Healthcare main competitors are Fractyl Health, Senzime, Nexstim, Pangaea Oncology. |
| What is the current market cap of Sensus Healthcare? | Sensus Healthcare's current market cap is $74M. |
| What is the current revenue of Sensus Healthcare? | Sensus Healthcare's last 12 months revenue is $27M. |
| What is the current revenue growth of Sensus Healthcare? | Sensus Healthcare revenue growth (NTM/LTM) is 9%. |
| What is the current EV/Revenue multiple of Sensus Healthcare? | Current revenue multiple of Sensus Healthcare is 1.9x. |
| Is Sensus Healthcare profitable? | No, Sensus Healthcare is not profitable. |
| What is the current EBITDA of Sensus Healthcare? | Sensus Healthcare has negative EBITDA and is not profitable. |
| What is Sensus Healthcare's EBITDA margin? | Sensus Healthcare's last 12 months EBITDA margin is (32%). |
| What is the current EV/EBITDA multiple of Sensus Healthcare? | Current EBITDA multiple of Sensus Healthcare is (6.0x). |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.